Details for Patent: 6,703,418
✉ Email this page to a colleague
Summary for Patent: 6,703,418
Title: | Appetite stimulation and induction of weight gain in patients suffering from symptomatic HIV infection |
Abstract: | Patients with symptomatic HIV infection, including AIDS and ARC are treated to increase appetite and to cause a reduction in loss of weight. The delta-9-tetrahydrocannabinol may be administered orally, in capsules, or in tablets, or by injection, suppository, intranasal, transdermal, inhalant or sublingual administration. |
Inventor(s): | Plasse; Terry (New York, NY) |
Assignee: | Unimed Pharmaceuticals, Inc. ( |
Application Number: | 07/893,554 |
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; Formulation; Delivery; |
Drugs Protected by US Patent 6,703,418
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |